AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/309% below fair value
$11.98−0.44 (-3.50%)
Close on Nov 12, 2026Market cap $504.02MP/E –Yield –
AngioDynamics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
AngioDynamics's price to sales ratio was 1.6× on Nov 11, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.7× to 3.6×, with a median of 1.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | −0.2 |
| 2025 | Dec 31, 2025 | 1.8× | +0.5 |
| 2024 | Dec 31, 2024 | 1.3× | +0.3 |
| 2023 | Dec 29, 2023 | 0.9× | −0.8 |
| 2022 | Dec 30, 2022 | 1.7× | −1.9 |
| 2021 | Dec 31, 2021 | 3.6× | +1.4 |
| 2020 | Dec 31, 2020 | 2.2× | −0.0 |
| 2019 | Dec 31, 2019 | 2.2× | −0.6 |
| 2018 | Dec 31, 2018 | 2.9× | +1.0 |
| 2017 | Dec 29, 2017 | 1.9× | +0.2 |
| 2016 | Dec 30, 2016 | 1.7× | +0.5 |
| 2015 | Dec 31, 2015 | 1.2× | −0.6 |
| 2014 | Dec 31, 2014 | 1.9× | +0.2 |
| 2013 | Dec 31, 2013 | 1.7× | +0.2 |
| 2012 | Dec 31, 2012 | 1.5× | −0.2 |
| 2011 | Dec 30, 2011 | 1.7× | −0.1 |
| 2010 | Dec 31, 2010 | 1.8× | – |
See a number that looks wrong?